The present study aims at exploring a detailed characterization of the binding interaction of a promising cancer cell photosensitizer, harmane (HM), with DNA extracted from herring sperm. The polarity-sensitive prototropic transformation of HM, a naturally occurring, fluorescent, drug-binding alkaloid, β-carboline, is remarkably modified upon interaction with DNA and is manifested through significant modulations on the absorption and emission profiles of HM. From the series of studies undertaken in the present program, for example, absorption; steady-state emission; the effect of chaotrope (urea); iodide ion-induced steady-state fluorescence quenching; circular dichroism (CD); and helix melting from absorption spectroscopy; the mode of binding of HM into the DNA helix has been substantiated to be principally intercalative. Concomitantly, a discernible dependence of the photophysics of the DNA-bound drug on the medium ionic strength indicates that electrostatic attraction should not be ignored in the interaction. Efforts have also been delivered to delineate the dynamical aspects of the interaction, such as modulation in time-resolved fluorescence decay and rotational relaxation dynamics of the drug within the DNA environment. In view of the prospective biological applications of HM, the issue of facile dissociation of intercalated HM from the DNA helix also comprises a crucial prerequisite for the functioning as an effective therapeutic agent. In this context, our results imply that the concept of detergent-sequestered dissociation of the drug from the drug-DNA complex can be a prospective strategy through an appropriate choice of the detergent molecule. The utility of the present work resides in exploring the potential applicability of the fluorescence property of HM for studying its interactions with a relevant biological target, for example, DNA. In addition, the methods and techniques used in the present work can also be exploited to study the interaction of HM with other biological, biomimicking assemblies and drug delivery vehicles, and so forth.

The present work describes the interaction of a promising cancer cell photosensitizer, harmane (HM), with a model transport protein, Bovine Serum Albumin (BSA). The studied molecule of interest (HM) belongs to the family of naturally occurring fluorescent drug-binding alkaloids, the β-carbolines. A combined use of steady-state and time-resolved fluorescence techniques is applied to follow and characterize the binding interaction. The polarity-dependent prototropic activity of HM is found to be responsible for the commendable sensitivity of the probe to the protein environments and is distinctly reflected on the emission profile. Steady-state fluorescence anisotropy study reveals the impartation of a considerable degree of motional restriction on the drug molecule as a result of binding to the protein. Contrary to the single-exponential nature of fluorescence anisotropy decay of HM in aqueous buffer, they are found to be biexponential in the protein environment. The rotational relaxation dynamics of HM within the protein has been interpreted on the lexicon of the Two-Step and Wobbling-in-Cone model. The probable binding location for the cationic drug is found to be the hydrophilic binding zone of BSA, i.e., domain I (characterized by a net negative charge). The AutoDock-based blind docking simulation has been explored for evaluating an unbiased result of the probable interaction site of HM in the protein. To unfold the effect of binding of the drug on the secondary structural content of the protein, circular dichroism (CD) spectroscopy has been exploited to see that binding of the drug accompanies some decrease in α-helical content of BSA, and the effect gradually saturates toward a higher drug/protein molar ratio.

A simple intramolecular charge transfer (ICT) compound, 5-(4-dimethylamino-phenyl)-penta-2,4-dienoic acid methyl ester (DPDAME), has been documented to be a potential molecular reporter for probing microheterogeneous environments of a model transport protein bovine serum albumin (BSA) using spectroscopic techniques. Meteoric modifications to the emission profile of DPDAME upon addition of BSA come out to be a result of its binding to hydrophobic subdomain IIA. The highly polarity-sensitive ICT emission of DPDAME is found to be a proficient extrinsic molecular reporter for efficient mapping of native, intermediate, unfolded, and refolded states of the protein. Experimental data coupled with a reinforcing support from theoretical simulation using CHARMM22 software confirm the binding site of the probe to be the subdomain IIA of BSA, while FRET study reveals a remarkably close approach of our extrinsic molecular reporter to Trp-212 (in domain IIA): the distance between DPDAME and Trp-212 is 1.437 nm. The caliber of DPDAME as an external fluorescence marker also extends to the depiction of protein-surfactant (BSA-SDS) interaction to commendable fruition. Additionally, the protective action of small amounts of SDS on urea-denatured protein is documented by polarity-sensitive ICT emission of the probe. The present study also reflects the enhancement of the stability of BSA with respect to chemically induced denaturation by urea as a result of binding to the probe DPDAME.

The present work demonstrates the modulation of excited state intramolecular proton transfer (ESIPT) emission of 1-hydroxy-2-naphthaldehyde (HN12) upon its interaction with the liposomal vesicles/bilayer of dimyristoyl-l-α-phosphatidylcholine (DMPC) and dimyristoyl-l-α-phosphatidylglycerol (DMPG) and its subsequent implementation as an efficient molecular reporter for probing of microheterogeneous environments of lipid-bilayer system. Modifications on the emission profile of HN12 in terms of remarkable emission intensity enhancement coupled with a hypsochromic shift induced by the presence of DMPC and DMPG membranes have been interpreted to be vivid manifestations of the interactions between the two partners. Steady-state anisotropy, red-edge excitation shift (REES), and time-resolved fluorescence measurements have been fruitfully exploited to complement other experimental findings. Probable binding site of HN12 in the lipid-bilayers has been assessed on the basis of intertwining the results of fluorescence quenching with other experimental results and is further substantiated from docking studies.

Infrared-ultraviolet double-resonance spectroscopy has been applied to discriminate rotamers of jet-cooled aryl alcohol homologues, φ-(CH 2 ) n OH, where φ represents phenyl group and n ) 1, 2, and 3 correspond to benzyl, phenethyl, and 3-phenylpropyl alcohols, respectively. Experimental results indicate that different OH stretching frequencies are associated with different rotamers and that the ability of intramolecular hydrogen bonding with the benzene π-electron decreases with an increase in alkyl chain length. In each aryl alcohol, the most prominent species in jets corresponds to the non-hydrogen-bonded rotamer having higher OH stretching frequency.

The excited-state intramolecular proton transfer (ESIPT) reaction of 1-hydroxy-2-naphthaldehyde (HN12) has been studied within the interior of the supramolecular assemblies of alpha-, beta-, and gamma-cyclodextrins (CD) and biomimicking environments of ionic (SDS) and non-ionic (TW-20) micelles. Fluorescence measurements are used to investigate the effect of various supramolecular assemblies on the ESIPT reaction by monitoring the large Stokes-shifted tautomer emission of HN12. Enhanced tautomer emission in the microencapsulated state predicts favorable ESIPT reaction in the supramoleuclar assemblies. Benesi-Hildebrand plots have been employed to ascertain that the stoichiometric ratios of the complexes formed between HN12 and CDs are 1:2, 1:1, and 1:1 for alpha-, beta-, and gamma-CD, respectively. The binding constants (K(1)) and free-energy change (DeltaG) for inclusion complexation are also determined from the linearized Benesi-Hildebrand plots. Steady-state fluorescence anisotropy, REES, excitation anisotropy, and fluorescence lifetime measurements are in line with other experimental findings. Differential action of urea on SDS and TW-20-bound probe has also been investigated.

The present contribution reports a detailed characterization of the binding interaction of a potential anticancer, anti-HIV drug 1-phenylisatin (1-PI) with a model transport protein Bovine Serum Albumin (BSA) using fluorescence spectroscopic techniques. The thermodynamic parameters e.g., ΔH, ΔS and ΔG for the binding phenomenon have been evaluated on the basis of the van't Hoff equation to reveal that the binding process is principally driven by ionic interactions mediated by charge transfer interaction. This line of argument has been substantiated by frontier molecular orbital analysis of 1-PI. However, the drug-induced quenching of the intrinsic tryptophanyl fluorescence of the protein is found not to abide by a linear Stern-Volmer regression (displaying an upward curvature) when an extensive time-resolved fluorescence spectroscopic characterization of the quenching process has been undertaken to unveil the actuating quenching mechanism. Based on the constancy of the fluorescence lifetime of the protein as a function of drug concentration the observed quenching is inferred to proceed through a static mechanism between the quenching partners. Constant wavelength synchronous fluorescence, excitation-emission matrix fluorescence and circular dichroic (CD) spectroscopic techniques have been exploited to unravel the tertiary and secondary conformational changes in the protein (BSA) induced by drug (1-PI)-binding. The probable binding location of the drug molecule within the protein cavity (hydrophilic subdomain I) has been explored by AutoDock-based blind docking simulation and the inference is further substantiated by site-competitive replacement experiments with specific site-markers. Light is also cast on the drug-protein binding kinetics using the stopped-flow fluorescence technique which reveals an association rate constant of k(a) (± 5%) = 1.471 × 10(-3) s(-1) for the interaction of 1-PI with BSA.

The present work demonstrates the photophysical characterization of the interaction of a promising cancer cell photosensitizer, harmane (HM), with biomimetic micellar nanocavities having varying surface charge characteristics. The polarity-sensitive prototropic transformation of HM is remarkably modified upon interaction with the macromolecular assemblies of micellar systems and is manifested through significant modulations on the absorption and emission profiles of HM. The ground- and excited-states prototropic equilibria of HM are found to be differentially modulated in various micellar assemblies. Out of various possibilities to assess the drug (HM)-micelle interaction mechanism, the postulate of varying extent of drug penetration into micellar units depending on the compactness of their headgroup arrangements is found to suitably rationalize and correlate different experimental findings, including the differences in binding constant (K) and free energy change (ΔG) of the interaction process. The micropolarity measurement has been exploited to evaluate the probable binding location of the drug which reveals that the cationic drug molecule does not penetrate deep into the micellar core region and the results are further substantiated from fluorescence quenching experiments. The work also pays proper attention to delineate the modulation in dynamical behaviors of the drug following interaction with the micellar systems. Wavelength-sensitive fluorescence parameters reveal the slower rate of solvent-relaxation around the excited probe within the micelle-encapsulated microheterogeneous environments. The enhancement of fluorescence anisotropy and rotational relaxation time of the drug in micellar environments from that in pure aqueous buffer suggests entrapment of the drug in motionally constrained regions introduced by the micelles.